Home
>
National Drug Code (NDC)
>
Kalexate
Kalexate - 10702-036-45 - (Sodium Polystyrene Sulfonate)
Drug Information of Kalexate
| Product NDC: | 10702-036 |
| Proprietary Name: | Kalexate |
| Non Proprietary Name: | Sodium Polystyrene Sulfonate |
| Active Ingredient(s): | 1 mg/g & nbsp; Sodium Polystyrene Sulfonate |
| Administration Route(s): | ORAL; RECTAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Kalexate
| Product NDC: | 10702-036 |
| Labeler Name: | KVK-Tech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040905 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120725 |
Package Information of Kalexate
| Package NDC: | 10702-036-45 |
| Package Description: | 454 g in 1 JAR (10702-036-45) |
NDC Information of Kalexate
| NDC Code | 10702-036-45 |
| Proprietary Name | Kalexate |
| Package Description | 454 g in 1 JAR (10702-036-45) |
| Product NDC | 10702-036 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sodium Polystyrene Sulfonate |
| Dosage Form Name | POWDER |
| Route Name | ORAL; RECTAL |
| Start Marketing Date | 20120725 |
| Marketing Category Name | ANDA |
| Labeler Name | KVK-Tech, Inc. |
| Substance Name | SODIUM POLYSTYRENE SULFONATE |
| Strength Number | 1 |
| Strength Unit | mg/g |
| Pharmaceutical Classes |
